EHSI Signs Option with Biotech Firm Celulas Genetica

Emerging Healthcare Solutions, Inc. (PinkSheets: EHSI) announced today that it locked down an option for a profit participation deal with biotech firm Celulas Genetica. Celulas Genetica works to develop new major medical solutions using adult stem cell research. This industry promises to be a major driver of growth in the medical and pharmaceutical industries over the next ten years. Celulas Genetica hopes to play a leading role in the development of new medical breakthroughs.

Billions of dollars have gone into adult stem cell research and breakthrough cures appear to be on the way. Celulas Genetica aims to provide stem cell research support to researchers and universities in Central and South America where there are fewer restrictions on such research than there are in the United States. Stem cell cures could produce billions of dollars of revenue for the companies that develop these cures and bring them to market.

The option agreement gives the companies a mutual due diligence review period prior to completing an investment and profit sharing agreement that could earn EHSI up to 20% of the Company’s long-term profits.

Stem cell research stocks in the Biotechnology sector that give context to the importance this exploding industry include ViaCell (NASDAQ: VIAC), a Cambridge Massachusetts company backed by biotech giant Amgen (NASDAQ: AMGN) and Genzyme (NASDAQ: GENZ). The Biotechnology sector also includes Biogen Idec (NASDAQ: BIIB).

About Emerging Healthcare Solutions, Inc.

Emerging Healthcare Solutions, Inc. invests in and participates in the profits of emerging breakthrough medical technologies. The Company believes the secret of leveraging major future value for its shareholders is the proper timing of its investment in promising new medical technologies. EHSI aims to capture future profits of promising new medical technologies by investing in these technologies at the inflection point of product development. We believe this model will deliver long-term positive results for our investors.

For more information, visit http://www.emerginghealthcaresolutionsinc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.